✦ LIBER ✦

A phase III study of concurrent radiotherapy with carboplatin or weekly paclitaxel in patients with advanced squamous cell head and neck cancer (SCHNC)

✍ Scribed by C. Andreadis; J. Sidiropoulos; K. Vahtsevanos; J. Thomaidis; E. Destouni; D. Kasfikis; D. Mouratidou

Book ID: 117667620
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 156 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81077-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly and 3-weekly cisplatin concurrent

Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer

✍ V. Espeli; E. Zucca; M. Ghielmini; O. Giannini; A. Salatino; F. Martucci; A. Ric 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Phase II Study Evaluating the Addition o

Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck

✍ Mohan Suntharalingam; Young Kwok; Olga Goloubeva; Arti Parekh; Rodney Taylor; Je 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Concomitant boost radiotherapy with conc

Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial

✍ Shaleen Kumar; Manish Pandey; Punita Lal; Neeraj Rastogi; K. Joseph Maria Das; K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Phase I study of concurrent carboplatin

Phase I study of concurrent carboplatin and radiotherapy in previously untreated patients with stage III and IV head and neck cancer

✍ Dr. David Osoba; Dr. Albino D. Flores; Dr. John H. Hay; Dr. Frances Wong; Ms. Ma 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

This study evaluated the toxicity resulting from combined therapy using carboplatin and radiotherapy in 22 patients with locally advanced (stage 111 and IV) head and neck cancer. Carboplatin was given after radiotherapy during the first 5 consecutive days of a 16-fraction course of radiotherapy deli

Randomized phase 2 study of concomitant

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

✍ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##